An Analysis of the COVID-19 Situation in India in Terms of Testing, Treatment, Vaccine Acceptance and National Economic Performance
- PMID: 36405526
- PMCID: PMC9667391
- DOI: 10.3389/ijph.2022.1604975
An Analysis of the COVID-19 Situation in India in Terms of Testing, Treatment, Vaccine Acceptance and National Economic Performance
Abstract
Objectives: This study aims to provide a comprehensive review on the analysis of COVID-19 pandemic in India and address economic impact, diagnosis approaches, and vaccine acceptance and hesitation. Method: We retrieved articles published in 2020 and 2021 and current data from official websites that narrate the strategy for COVID-19 testing, issues, and challenges, healthcare system insufficiency, statistics of cases, deaths, vaccination, and vaccine acceptance barriers, and beliefs. Results: India being the 2nd largest populated country with a population of 1.4 billion faced massive difficulty in controlling the transmission of SARS-CoV-2. This crisis dramatically impeded the economy of the nation. India witnessed 2nd highest number (43,019,453) of confirmed cases and 3rd highest number of deaths (521,004) across the world. Conclusion: The major cause of the collapse of COVID-19 is the high population of India, pre-existing weak healthcare system, and the lack of awareness among the people. The fall, rise, and statistics provided in the review will help in comparing the current status with other countries and in making strong strategies to combat future calamities.
Keywords: COVID-19 in India; COVID-19 statistics of India; COVID-19 testing; Coronavirus Vaccine; Economic impact of coronavirus; Indian healthcare system.
Copyright © 2022 Patel and Patel.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
A Cross-sectional Survey of Public Knowledge and Perspective on Coronavirus Disease, Vaccination, and Related Research in India during the COVID-19 Pandemic.J Assoc Physicians India. 2023 Sep;71(9):19-27. doi: 10.59556/japi.71.0335. J Assoc Physicians India. 2023. PMID: 38700297
-
COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type.Viruses. 2023 Oct 30;15(11):2181. doi: 10.3390/v15112181. Viruses. 2023. PMID: 38005859 Free PMC article.
-
The impact of geo-political socio-economic factors on vaccine dissemination trends: a case-study on COVID-19 vaccination strategies.BMC Public Health. 2023 Nov 2;23(1):2142. doi: 10.1186/s12889-023-17000-z. BMC Public Health. 2023. PMID: 37919737 Free PMC article.
-
COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors.PLoS One. 2022 May 11;17(5):e0267691. doi: 10.1371/journal.pone.0267691. eCollection 2022. PLoS One. 2022. PMID: 35544545 Free PMC article. Review.
-
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Review.
Cited by
-
Out-of-Pocket Expenditure (OOPE) Among COVID-19 Patients by Insurance Status in a Quaternary Hospital in Karnataka, India.Int J Environ Res Public Health. 2025 Aug 18;22(8):1289. doi: 10.3390/ijerph22081289. Int J Environ Res Public Health. 2025. PMID: 40869874 Free PMC article.
-
Facile green synthesis of silver nanoparticles derived from the medicinal plant Clerodendrum serratum and its biological activity against Mycobacterium species.Heliyon. 2024 May 10;10(10):e31116. doi: 10.1016/j.heliyon.2024.e31116. eCollection 2024 May 30. Heliyon. 2024. PMID: 38799742 Free PMC article.
-
Effectiveness of and Inequalities in COVID-19 Epidemic Control Strategies in Hungary: A Nationwide Cross-Sectional Study.Healthcare (Basel). 2023 Apr 25;11(9):1220. doi: 10.3390/healthcare11091220. Healthcare (Basel). 2023. PMID: 37174762 Free PMC article.
-
Risk and protective factors against cognitive decline in older adults from a nationally representative sample in India: Results from the LASI-DAD.medRxiv [Preprint]. 2025 Jul 10:2025.07.07.25331027. doi: 10.1101/2025.07.07.25331027. medRxiv. 2025. PMID: 40672514 Free PMC article. Preprint.
References
-
- Ritchie H, Mathieu E, Rodes-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, et al. Coronavirus Pandemic (COVID-19). Our World in Data (2020-2021). Available from: https://ourworldindata.org/coronavirus (Accessed March 31, 2022).
-
- India Covid-19: PM Modi 'did Not Consult' before Lockdown. BBC News (2021). Available from: https://www.bbc.com/news/world-asia-india-56561095 (Accessed March 29, 2021).
-
- Gettleman J, Schultz K. Modi Orders 3-Week Total Lockdown for All 1.3 Billion Indians. The New York Times (2020). ISSN 0362-4331. Available from: https://www.nytimes.com/2020/03/24/world/asia/india-coronavirus-lockdown... (Accessed March 24, 2020).
-
- Coronavirus Lockdown Extended till 31 May, Says NDMA. LiveMint (2020). Available from: https://www.livemint.com/news/india/covid-19-lockdown-4-0-coronavirus-lo... (Accessed May 17, 2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous